Intraocular vaccination with an inactivated highly pathogenic avian influenza virus induces protective antibody responses in chickens

Veterinary Immunology and Immunopathology

Volumn 151, Issue 1-2, 2013, Pages 83-89

  Hikono, Hirokazu ^a   Mase, Masaji ^a   Matsuu, Aya ^a   Nakayama, Megumi ^a   Saito, Takehiko ^a  

^a NATIONAL INSTITUTE OF ANIMAL HEALTH   (Japan)

Author keywords

Avian influenza; Chicken; Intraocular vaccination; Vaccine

Indexed keywords

AVIAN INFLUENZA VACCINE; CHOLERA TOXIN; CPG OLIGODEOXYNUCLEOTIDE; CROSS REACTING ANTIBODY; HEMAGGLUTINATION INHIBITING ANTIBODY; IMMUNOGLOBULIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; AVIAN INFLUENZA VIRUS; CHICKEN; CONTROLLED STUDY; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMAGGLUTINATION; INFLUENZA; INFLUENZA A (H5N1); INOCULATION; MOUTH MUCOSA; NONHUMAN; VIRUS IMMUNITY; VIRUS SHEDDING;

ANIMALS; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; CHICKENS; CROSS REACTIONS; IMMUNITY, MUCOSAL; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA VACCINES; INJECTIONS, INTRAMUSCULAR; OPHTHALMIC SOLUTIONS; OROPHARYNX; VACCINATION; VACCINES, INACTIVATED;

AVES; AVIAN INFLUENZA VIRUS; GALLUS GALLUS;

EID: 84871707593     PISSN: 01652427     EISSN: 18732534     Source Type: Journal    
DOI: 10.1016/j.vetimm.2012.10.005     Document Type: Article

References (41)

1. Brownlie R., Zhu J., Allan B., Mutwiri G.K., Babiuk L.A., Potter A., Griebel P. Chicken TLR21 acts as a functional homologue to mammalian TLR9 in the recognition of CpG oligodeoxynucleotides. Mol. Immunol. 2009, 46:3163-3170.
2. Burns R.B. Possible route of antigen uptake by the Harderian gland of the domestic fowl. Br. Poult. Sci. 1977, 18:407-408.
3. Cattoli G., Fusaro A., Monne I., Coven F., Joannis T., El-Hamid H.S., Hussein A.A., Cornelius C., Amarin N.M., Mancin M., Holmes E.C., Capua I. Evidence for differing evolutionary dynamics of A/H5N1 viruses among countries applying or not applying avian influenza vaccination in poultry. Vaccine 2011, 29:9368-9375.
4. Chen H. Avian influenza vaccination: the experience in China. Rev. Sci. Tech. 2009, 28:267-274.
5. Dalloul R.A., Lillehoj H.S., Okamura M., Xie H., Min W., Ding X., Heckert R.A. In vivo effects of CpG oligodeoxynucleotide on Eimeria infection in chickens. Avian Dis. 2004, 48:783-790.
6. Domenech J., Dauphin G., Rushton J., McGrane J., Lubroth J., Tripodi A., Gilbert J., Sims L.D. Experiences with vaccination in countries endemically infected with highly pathogenic avian influenza: the Food and Agriculture Organization perspective. Rev. Sci. Tech. 2009, 28:293-305.
7. Gambotto A., Barratt-Boyes S.M., de Jong M.D., Neumann G., Kawaoka Y. Human infection with highly pathogenic H5N1 influenza virus. Lancet 2008, 371:1464-1475.
8. Geeraedts F., Goutagny N., Hornung V., Severa M., de Haan A., Pool J., Wilschut J., Fitzgerald K.A., Huckriede A. Superior immunogenicity of inactivated whole virus H5N1 influenza vaccine is primarily controlled by Toll-like receptor signalling. PLoS Pathog. 2008, 4:e1000138.
9. Girard F., Péry P., Naciri M., Quéré P. Adjuvant effect of cholera toxin on systemic and mucosal immune responses in chickens infected with E. tenella or given recombinant parasitic antigen per os. Vaccine 1999, 17:1516-1524.
10. Hikono H., Miyazaki A., Mase M., Inoue M., Hasegawa M., Saito T. Induction of a cross-reactive antibody response to influenza virus M2 antigen in pigs by using a Sendai virus vector. Vet. Immunol. Immunopathol. 2012, 146:92-96.
11. Holmgren J., Czerkinsky C. Mucosal immunity and vaccines. Nat. Med. 2005, 11:S45-S53.
12. Jayawardane G.W., Spradbrow P.B. Mucosal immunity in chickens vaccinated with the V4 strain of Newcastle disease virus. Vet. Microbiol. 1995, 46:69-77.
13. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observation. J. Am. Stat. Assoc. 1958, 53:457-481.
14. Keestra A.M., de Zoete M.R., Bouwman L.I., van Putten J.P. Chicken TLR21 is an innate CpG DNA receptor distinct from mammalian TLR9. J. Immunol. 2010, 185:460-467.
15. Kida H., Yanagawa R. Classification of avian paramyxoviruses by immunodiffusion on the basis of antigenic specificity of their M protein antigens. J. Gen. Virol. 1981, 52:103-111.
16. Kim J.K., Kayali G., Walker D., Forrest H.L., Ellebedy A.H., Griffin Y.S., Rubrum A., Bahgat M.M., Kutkat M.A., Ali M.A., Aldridge J.R., Negovetich N.J., Krauss S., Webby R.J., Webster R.G. Puzzling inefficiency of H5N1 influenza vaccines in Egyptian poultry. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:11044-11049.
17. King D.J. Evaluation of different methods of inactivation of Newcastle disease virus and avian influenza virus in egg fluids and serum. Avian Dis. 1991, 35:505-514.
18. Lee C.W., Senne D.A., Suarez D.L. Effect of vaccine use in the evolution of Mexican lineage H5N2 avian influenza virus. J. Virol. 2004, 78:8372-8381.
19. Martins N.R., Mockett A.P., Barrett A.D., Cook J.K. Local and systemic antibody class responses to an infectious laryngotracheitis virus vaccine strain. Avian Pathol. 1992, 21:97-106.
20. Quan F.S., Compans R.W., Nguyen H.H., Kang S.M. Induction of heterosubtypic immunity to influenza virus by intranasal immunization. J. Virol. 2008, 82:1350-1359.
21. Rajini B., Zeng J., Suvas P.K., Dech H.M., Onami T.M. Both systemic and mucosal LCMV immunization generate robust viral-specific IgG in mucosal secretions but elicit poor LCMV-specific IgA. Viral Immunol. 2010, 23:377-384.
22. Rankin R., Pontarollo R., Ioannou X., Krieg A.M., Hecker R., Babiuk L.A., van Drunen Littel-van den Hurk S. CpG motif identification for veterinary and laboratory species demonstrates that sequence recognition is highly conserved. Antisense Nucleic Acid Drug Dev. 2001, 11:333-340.
23. Reed L.J., Muench H. A simple method of estimating 50% endopoints. Am. J. Hyg. 1938, 27:493-497.
24. Sasaki T., Isoda N., Soda K., Sakamoto R., Saijo K., Hagiwara J., Kokumai N., Ohgitani T., Imamura T., Sawata A., Lin Z., Sakoda Y., Kida H. Evaluation of the potency, optimal antigen level and lasting immunity of inactivated avian influenza vaccine prepared from H5N1 virus. Jpn. J. Vet. Res. 2009, 56:189-198.
25. Suarez D.L. Avian influenza: our current understanding. Anim. Health Res. Rev. 2010, 11:19-33.
26. Swayne D.E. Principles for vaccine protection in chickens and domestic waterfowl against avian influenza: emphasis on Asian H5N1 high pathogenicity avian influenza. Ann. N.Y. Acad. Sci. 2006, 1081:174-181.
27. Swayne D.E., Pavade G., Hamilton K., Vallet B., Miyagishima K. Assessment of national strategies for control of high-pathogenicity avian influenza and low-pathogenicity notifiable avian influenza in poultry, with emphasis on vaccines and vaccination. Rev. Sci. Tech. 2011, 30:839-870.
28. Takada A., Kida H. Protective immune response of chickens against Newcastle disease, induced by the intranasal vaccination with inactivated virus. Vet. Microbiol. 1996, 50:17-25.
29. Takada A., Matsushita S., Ninomiya A., Kawaoka Y., Kida H. Intranasal immunization with formalin-inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza A virus infection in mice. Vaccine 2003, 21:3212-3218.
30. Tamura S., Kurata T. Defense mechanisms against influenza virus infection in the respiratory tract mucosa. Jpn. J. Infect. Dis. 2004, 57:236-247.
31. Tumpey T.M., Renshaw M., Clements J.D., Katz J.M. Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection. J. Virol. 2001, 75:5141-5150.
32. van Ginkel F.W., Tang D.C., Gulley S.L., Toro H. Induction of mucosal immunity in the avian Harderian gland with a replication-deficient Ad5 vector expressing avian influenza H5 hemagglutinin. Dev. Comp. Immunol. 2009, 33:28-34.
33. van Ginkel F.W., Gulley S.L., Lammers A., Hoerr F.J., Gurjar R., Toro H. Conjunctiva-associated lymphoid tissue in avian mucosal immunity. Dev. Comp. Immunol. 2012, 36:289-297.
34. Vujanic A., Sutton P., Snibson K.J., Yen H.H., Scheerlinck J.P. Mucosal vaccination: lung versus nose. Vet. Immunol. Immunopathol. 2012, 148:172-177.
35. Wang Y., Shan C., Ming S., Liu Y., Du Y., Jiang G. Immunoadjuvant effects of bacterial genomic DNA and CpG oligodeoxynucleotides on avian influenza virus subtype H5N1 inactivated oil emulsion vaccine in chicken. Res. Vet. Sci. 2009, 86:399-405.
36. Wattrang E. Phosphorothioate oligodeoxyribonucleotides induce in vitro proliferation of chicken B-cells. Vet. Immunol. Immunopathol. 2009, 131:218-228.
37. Xiaowen Z., Qinghua Y., Xiaofei Z., Qian Y. Co-administration of inactivated avian influenza virus with CpG or rIL-2 strongly enhances the local immune response after intranasal immunization in chicken. Vaccine 2009, 27:5628-5632.
38. Yaguchi K., Ohgitani T., Noro T., Kaneshige T., Shimizu Y. Vaccination of chickens with liposomal inactivated avian pathogenic Escherichia coli (APEC) vaccine by eye drop or coarse spray administration. Avian Dis. 2009, 53:245-249.
39. Yen H.H., Scheerlinck J.P., Gekas S., Sutton P. A sheep cannulation model for evaluation of nasal vaccine delivery. Methods 2006, 38:117-123.
40. Yoshikawa T., Matsuo K., Matsuo K., Suzuki Y., Nomoto A., Tamura S., Kurata T., Sata T. Total viral genome copies and virus-Ig complexes after infection with influenza virus in the nasal secretions of immunized mice. J. Gen. Virol. 2004, 85:2339-2346.
41. Zhang L., Zhang M., Li J., Cao T., Tian X., Zhou F. Enhancement of mucosal immune responses by intranasal co-delivery of Newcastle disease vaccine plus CpG oligonucleotide in SPF chickens in vivo. Res. Vet. Sci. 2008, 85:495-502.